These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

201 related items for PubMed ID: 14614695

  • 1. Sclerotherapy treatment of telangiectasias and varicose veins.
    Zimmet SE.
    Tech Vasc Interv Radiol; 2003 Sep; 6(3):116-20. PubMed ID: 14614695
    [Abstract] [Full Text] [Related]

  • 2. Venous disorders: treatment with sclerosant foam.
    Bergan J, Pascarella L, Mekenas L.
    J Cardiovasc Surg (Torino); 2006 Feb; 47(1):9-18. PubMed ID: 16434941
    [Abstract] [Full Text] [Related]

  • 3. Standard guidelines for care: sclerotherapy in dermatology.
    Khunger N, Sacchidanand S.
    Indian J Dermatol Venereol Leprol; 2011 Feb; 77(2):222-31. PubMed ID: 21393966
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Visual disturbance following sclerotherapy for varicose veins, reticular veins and telangiectasias: a systematic literature review.
    Willenberg T, Smith PC, Shepherd A, Davies AH.
    Phlebology; 2013 Apr; 28(3):123-31. PubMed ID: 23761921
    [Abstract] [Full Text] [Related]

  • 7. Effectiveness and safety of ultrasound-guided foam sclerotherapy for recurrent varicose veins: immediate results.
    Kakkos SK, Bountouroglou DG, Azzam M, Kalodiki E, Daskalopoulos M, Geroulakos G.
    J Endovasc Ther; 2006 Jun; 13(3):357-64. PubMed ID: 16784324
    [Abstract] [Full Text] [Related]

  • 8. Comparison of efficacy and safety between foam sclerotherapy and conventional sclerotherapy: a controlled clinical trial.
    Ukritmanoroat T.
    J Med Assoc Thai; 2011 Mar; 94 Suppl 2():S35-40. PubMed ID: 21717876
    [Abstract] [Full Text] [Related]

  • 9. Liquid and Foam Sclerotherapy for Spider and Varicose Veins.
    Gibson K, Gunderson K.
    Surg Clin North Am; 2018 Apr; 98(2):415-429. PubMed ID: 29502781
    [Abstract] [Full Text] [Related]

  • 10. Injection sclerotherapy for varicose veins.
    Tisi PV, Beverley CA.
    Cochrane Database Syst Rev; 2002 Apr; (1):CD001732. PubMed ID: 11869605
    [Abstract] [Full Text] [Related]

  • 11. Sclerotherapy of varicose and telangiectatic leg veins. Minimal sclerosant concentration of hypertonic saline and its relationship to vessel diameter.
    Sadick NS.
    J Dermatol Surg Oncol; 1991 Jan; 17(1):65-70. PubMed ID: 1991883
    [Abstract] [Full Text] [Related]

  • 12. Ultrasound guided foam sclerotherapy: factors associated with outcomes and complications.
    Thomasset SC, Butt Z, Liptrot S, Fairbrother BJ, Makhdoomi KR.
    Eur J Vasc Endovasc Surg; 2010 Sep; 40(3):389-92. PubMed ID: 20547076
    [Abstract] [Full Text] [Related]

  • 13. Prospective randomised comparative study of visual foam sclerotherapy alone or in combination with ultrasound-guided foam sclerotherapy for treatment of superficial venous insufficiency: preliminary report.
    Yamaki T, Hamahata A, Soejima K, Kono T, Nozaki M, Sakurai H.
    Eur J Vasc Endovasc Surg; 2012 Mar; 43(3):343-7. PubMed ID: 22230599
    [Abstract] [Full Text] [Related]

  • 14. Experience with concomitant ultrasound-guided foam sclerotherapy and endovenous laser treatment in chronic venous disorder and its influence on Health Related Quality of Life: interim analysis of more than 1000 consecutive procedures.
    King T, Coulomb G, Goldman A, Sheen V, McWilliams S, Guptan RC.
    Int Angiol; 2009 Aug; 28(4):289-97. PubMed ID: 19648872
    [Abstract] [Full Text] [Related]

  • 15. Saphenous ablation: sclerosant or sclerofoam?
    Coleridge Smith P.
    Semin Vasc Surg; 2005 Mar; 18(1):19-24. PubMed ID: 15791549
    [Abstract] [Full Text] [Related]

  • 16. Sclerotherapy for varicose and telangiectatic veins.
    Green D.
    Am Fam Physician; 1992 Sep; 46(3):827-37. PubMed ID: 1514476
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Telangiectasias resistant to sclerotherapy are commonly connected to a perforating vessel.
    Schuller-Petrović S, Pavlović MD, Schuller S, Schuller-Lukic B, Adamic M.
    Phlebology; 2013 Sep; 28(6):320-3. PubMed ID: 22865418
    [Abstract] [Full Text] [Related]

  • 19. Efficacy and safety of great saphenous vein sclerotherapy using standardised polidocanol foam (ESAF): a randomised controlled multicentre clinical trial.
    Rabe E, Otto J, Schliephake D, Pannier F.
    Eur J Vasc Endovasc Surg; 2008 Feb; 35(2):238-45. PubMed ID: 17988905
    [Abstract] [Full Text] [Related]

  • 20. The V-Block Occlusion Stent and Sclerotherapy Device for Varicose Vein Treatment: A Retrospective Analysis.
    Kolvenbach RR, Elias S, Belinky A, Brandeis Z.
    Ann Vasc Surg; 2019 Aug; 59():231-236. PubMed ID: 31009711
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.